Mads Jorgen Nohr Clausen
Vorsitzender bei Clausen Controls Holding Ii ApS
Aktive Positionen von Mads Jorgen Nohr Clausen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MC2 Therapeutics Ltd.
 MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Direktor/Vorstandsmitglied | 25.06.2008 | - |
Clausen Controls Holding Ii ApS
 Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Vorsitzender | 04.05.2022 | - |
Karriereverlauf von Mads Jorgen Nohr Clausen
Statistik
International
| Vereinigtes Königreich | 2 |
| Dänemark | 2 |
Operativ
| Director/Board Member | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MC2 Therapeutics Ltd.
MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Health Technology |
Clausen Controls Holding Ii ApS
Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Finance |
